Vivo Capital, LLC Rezolute, Inc. Transaction History
Vivo Capital, LLC
- $512 Million
- Q4 2024
A detailed history of Vivo Capital, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 2,797,704 shares of RZLT stock, worth $13.1 Million. This represents 2.6% of its overall portfolio holdings.
Number of Shares
2,797,704
Previous 2,797,704
-0.0%
Holding current value
$13.1 Million
Previous $13.6 Million
1.64%
% of portfolio
2.6%
Previous 1.99%
Shares
4 transactions
Others Institutions Holding RZLT
# of Institutions
76Shares Held
44.6MCall Options Held
201KPut Options Held
2.8K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$53 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$13.4 Million0.69% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$11.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$10.9 Million0.0% of portfolio
-
Blackstone Inc New York, NY1.74MShares$8.2 Million0.04% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $182M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...